Sachem Capital Corp. 7.125% Not
Sachem Capital Corp. 7.125% Not (SCCF) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Sachem Capital Corp. 7.125% Not (SCCF), covering cash flow, earnings, and balance sheets.
Sachem Capital Corp. 7.125% Not (SCCF) Income Statement & Financial Overview
Review Sachem Capital Corp. 7.125% Not SCCF income statement with detailed quarterly and annual figures.
Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
---|---|---|---|---|
Revenue | $10.78M | $11.44M | -$11.21M | $14.79M |
Cost of Revenue | $0.00 | $92000.00 | $479000.00 | $290000.00 |
Gross Profit | $0.00 | $11.44M | $10.07M | $14.49M |
Gross Profit Ratio | $0.00 | $1.00 | -$0.90 | $0.98 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $1.30M | $1.35M | -$1.26M | $2.30M |
Operating Expenses | $9.71M | $10.41M | $4.51M | $19.32M |
Total Costs & Expenses | $0.00 | $10.41M | $18.46M | $19.61M |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
Depreciation & Amortization | $0.00 | $92000.00 | $91000.00 | $0.00 |
EBITDA | $1.07M | $7.09M | -$29.57M | -$4.82M |
EBITDA Ratio | $0.10 | $0.62 | $2.64 | -$0.33 |
Operating Income | $1.07M | $7.00M | -$20.86M | -$4.82M |
Operating Income Ratio | $0.10 | $0.61 | $1.86 | -$0.33 |
Other Income/Expenses (Net) | -$297000.00 | -$1.24M | -$18.48M | -$1.32M |
Income Before Tax | $769000.00 | -$213000.00 | -$39.34M | -$6.15M |
Income Before Tax Ratio | $0.07 | -$0.02 | $3.51 | -$0.42 |
Income Tax Expense | $0.00 | $0.00 | -$43.88M | $0.00 |
Net Income | $769000.00 | -$213000.00 | -$36.13M | -$6.15M |
Net Income Ratio | $0.07 | -$0.02 | $3.22 | -$0.42 |
EPS | $0.02 | -$0.005 | $0.14 | -$0.10 |
Diluted EPS | $0.02 | -$0.005 | $0.14 | -$0.14 |
Weighted Avg Shares Outstanding | $46.88M | $46.78M | $47.41M | $58.89M |
Weighted Avg Shares Outstanding (Diluted) | $46.88M | $44.24M | $47.41M | $44.24M |
Over the past four quarters, Sachem Capital Corp. 7.125% Not demonstrated steady revenue growth, increasing from $14.79M in Q3 2024 to $10.78M in Q2 2025. Operating income reached $1.07M in Q2 2025, maintaining a consistent 10% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $1.07M, reflecting operational efficiency. Net income rose to $769000.00, with EPS at $0.02. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan